Pharma industry in a sweet spot after market correction
- Analysts say most concerns have been priced in and that the sector may fare better in future
NEW DELHI : The Nifty Pharma index has declined 4.65% in the year so far as market volatility and raw material prices surged following the Russian invasion of Ukraine, but analysts believe that a large part of the concerns have been priced in, and the sector is expected to fare better in the coming quarters.
Login to enjoy exclusive benefits!
- Unlocked premium articles
- Personalized news
- Market Watchlist
- Insightful Newsletters & more